Investing.com – United States equities were lower at the close on Thursday, as losses in the Dow Jones Industrials, Dow Jones ...

U.S. stocks were lower after the close on Thursday, as losses in the Industrials, Healthcare and Consumer Goods sectors led ...

Nuvectis Pharma, Inc. (NASDAQ:NVCT) stock is trading lower after the company reported data from the Phase 1b study evaluating ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate.

Diversity workforce solutions company CareerCircle LLC, an Allegis Group brand, announced today Managing Director Kim Sneeder has been named to Staffing Industry Analysts' 2024 Global Power 150.

Nuvectis Pharma (NVCT) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed ...